Penicillamine

This classification denotes an angiogenesis activator inhibitor with the molecular formula C5H11NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) GNN1DV99GX, chemically known as valine, 3-mercapto-, l- but more generally known as penicillamine, which bears US NIH Compound Identifier 4727. European Medicines Agency schedules Penicillamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09667MIG. The term PENICILLAMINE is an International Non-Proprietary Name. World Health Organization schedules penicillamine in its Anatomical Therapeutic Chemical (ATC) Classification. PENICILLAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule penicillamine under HS 29309016 and SITC 51549. As of Q4 2014, PENICILLAMINE remains US FDA's Preferred Term for this commodity. Penicillamine bears US NLM identifiers UMLS ID C0030817 and NCI Concept Code C729. SMILES: SC(C(N)C(=O)O)(C)C.